| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 3 |
| 1 | ENTECAVIR ANHYDROUS | 3 |
| 2 | RITUXIMAB | 3 |
| 3 | ALBUMIN (HUMAN) | 2 |
| 4 | ALBUMIN HUMAN | 2 |
| 5 | CARBOPLATIN | 2 |
| 6 | CYCLOPHOSPHAMIDE | 2 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 9 | DEXAMETHASONE SODIUM PHOSPHATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 1 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 2 | FOSNETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| 3 | NETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| 4 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 5 | GLUTATHIONE | 1 | 0.0006 |
| 6 | UREA | 1 | 0.0005 |
| 7 | ALBUMIN HUMAN | 2 | 0.0004 |
| 8 | NICOTINAMIDE | 1 | 0.0004 |
| 9 | ALBUMIN (HUMAN) | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | Penem Antibacterial [EPC] | 2 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |